Literature DB >> 8703834

The reduction of large von Willebrand factor multimers in plasma in essential thrombocythaemia is related to the platelet count.

P J van Genderen1, U Budde, J J Michiels, R van Strik, H H van Vliet.   

Abstract

We have investigated the relationship between platelet count and large VWF (von Willebrand factor) multimers in the plasma of 36 patients with essential thrombocythaemia (ET) and 26 patients with reactive thrombocytosis (RT). In both ET and RT patients an inverse relationship could be established between platelet count and large VWF multimers in plasma as well in relatively decreased ristocetin cofactor/von Willebrand factor antigen and collagen binding activity/von Willebrand factor antigen ratios. A normalization of the platelet count was accompanied by restoration of a normal plasma VWF multimeric distribution. Our data suggest that increasing numbers of platelets circulating in blood result in increased removal of large VWF multimers from plasma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8703834     DOI: 10.1046/j.1365-2141.1996.d01-1729.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  8 in total

1.  Antihemophilic Factor/von Willebrand Factor Complex (Human), Dried, Pasteurized.

Authors: 
Journal:  P T       Date:  2010-01

2.  Mechanoenzymatic cleavage of the ultralarge vascular protein von Willebrand factor.

Authors:  Xiaohui Zhang; Kenneth Halvorsen; Cheng-Zhong Zhang; Wesley P Wong; Timothy A Springer
Journal:  Science       Date:  2009-06-05       Impact factor: 47.728

3.  Challenges in the treatment of patients with essential thrombocythemia and acute coronary syndrome.

Authors:  Christina Doesch; Björn Krämer; Tobias Geisler; Andreas E May; Stefan-Martin Kroeber; Reinhard Kandolf; Meinrad Gawaz
Journal:  J Thromb Thrombolysis       Date:  2007-08-14       Impact factor: 2.300

4.  Thrombocytosis: diagnostic evaluation, thrombotic risk stratification, and risk-based management strategies.

Authors:  Jonathan S Bleeker; William J Hogan
Journal:  Thrombosis       Date:  2011-06-08

Review 5.  Essential thrombocythemia.

Authors:  Jean B Brière
Journal:  Orphanet J Rare Dis       Date:  2007-01-08       Impact factor: 4.123

6.  Triple-Negative Essential Thrombocythemia Complicated by Thrombosis and Acquired von Willebrand Disease in a Young Man.

Authors:  Tejaswi Kanderi; Max Puthenpura; Isha Shrimanker; Fnu Sapna; Scott C Felter
Journal:  Am J Case Rep       Date:  2020-08-23

Review 7.  Prefibrotic myelofibrosis: treatment algorithm 2018.

Authors:  Guido Finazzi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-11-07       Impact factor: 11.037

Review 8.  The Intriguing Connections between von Willebrand Factor, ADAMTS13 and Cancer.

Authors:  Chanukya K Colonne; Emmanuel J Favaloro; Leonardo Pasalic
Journal:  Healthcare (Basel)       Date:  2022-03-16
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.